Bill Text — May 14, 2013
This bill’s text is now available.
May 22, 2012
112th Congress, 2011–2013
This bill was introduced on May 22, 2012, in a previous session of Congress, but was not enacted.
Representative for Maryland's 7th congressional district
Read Text »
Last Updated: May 22, 2012
Length: 11 pages
To prohibit wholesalers from purchasing prescription drugs from pharmacies, and to enhance information and transparency regarding drug wholesalers engaged in interstate commerce.
5/22/2012--Introduced.Gray Market Drug Reform and Transparency Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to:(1) make it a prohibited act and a misbranding for a wholesale ... Read more >
The bill’s title was written by its sponsor.
This is the first step in the legislative process.
Reintroduced Bill — Introduced
This activity took place on a related bill, H.R. 1958 (113th).
This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 5853”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The committee chair determines whether a bill will move past the committee stage.
There have been no roll call votes related to this bill.
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 5853 — 112th Congress: Gray Market Drug Reform and Transparency Act of 2012. Retrieved from https://www.govtrack.us/congress/bills/112/hr5853
“H.R. 5853 — 112th Congress: Gray Market Drug Reform and Transparency Act of 2012.” www.GovTrack.us. 2012. November 30, 2015 <https://www.govtrack.us/congress/bills/112/hr5853>
|title=H.R. 5853 (112th)
|accessdate=November 30, 2015
|author=112th Congress (2012)
|date=May 22, 2012
|quote=Gray Market Drug Reform and Transparency Act of 2012